Morgan Stanley (MS) 13D/13G Filings for BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc. (DCF)

Morgan Stanley 13D and 13G filings for BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-11-06
4:35 pm
Sale
2024-09-3013GBNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc.
DCF
MORGAN STANLEY
MS
586,098
3.900%
-298,635decrease
(-33.75%)
Filing
2024-02-12
12:11 pm
Sale
2023-12-3113GBNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc.
DCF
MORGAN STANLEY
MS
884,733
5.900%
-264,317decrease
(-23.00%)
Filing
2023-02-08
1:00 pm
Purchase
2022-12-3013GBNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc.
DCF
MORGAN STANLEY
MS
1,149,050
7.700%
27,009increase
(+2.41%)
Filing
2022-02-09
4:32 pm
Sale
2021-12-3113GBNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc.
DCF
MORGAN STANLEY
MS
1,122,041
7.500%
-176,165decrease
(-13.57%)
Filing
2021-02-10
2:26 pm
Purchase
2020-12-3113GBNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc.
DCF
MORGAN STANLEY
MS
1,298,206
8.700%
176,048increase
(+15.69%)
Filing
2020-02-12
5:12 pm
Purchase
2019-12-3113GBNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc.
DCF
MORGAN STANLEY
MS
1,122,158
7.500%
1,122,158increase
(New Position)
Filing